Enliven Therapeutics
ELVN
#3751
Rank
NZ$6.25 B
Marketcap
NZ$85.06
Share price
0.26%
Change (1 day)
119.59%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2026 (TTM): -NZ$0.22 Billion

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.22 Billion a decrease over its 2024 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.22 Billion-1.07%
2025 -NZ$0.22 Billion14.45%
2024 -NZ$0.2 Billion25.17%
2023 -NZ$0.16 Billion115.33%
2022 -NZ$70.91 Million